{
    "title": "Vaccines and drugs in the pipeline for RSV",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11445063/Vaccines-drugs-pipeline-RSV.html",
    "date": "2022-11-18",
    "keywords": [
        "vaccine",
        "study",
        "rsv",
        "latestage",
        "drug",
        "year",
        "trial",
        "johnson",
        "respiratory",
        "approval",
        "shot",
        "inc",
        "virus",
        "illness",
        "sanofi",
        "sa",
        "drugmaker",
        "nirsevimab",
        "merck",
        "coldlike",
        "hospitalization",
        "second",
        "orphan",
        "handful",
        "company",
        "yearend",
        "pfizer",
        "goal",
        "august",
        "plcs",
        "infection",
        "food",
        "administration",
        "fda",
        "decision",
        "application",
        "astrazeneca",
        "month",
        "plc",
        "authorization",
        "antibody",
        "treatment",
        "disease",
        "march",
        "efficacy",
        "tract",
        "placebo",
        "bodys",
        "infectionfighting",
        "breakthrough",
        "therapy",
        "designation",
        "review",
        "end",
        "moderna",
        "covid",
        "vaccinemaker",
        "messenger",
        "rna",
        "mrna",
        "technology",
        "development",
        "coronavirus",
        "winter",
        "co",
        "clesrovimab",
        "nordic",
        "april",
        "mid2023",
        "reporting",
        "raghav",
        "mahobe",
        "srinivasan",
        "bengaluru",
        "editing",
        "syamnath"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}